Zevra Therapeutics Taps Neil F. McFarlane as CEO and Director Succeeding Interim CEO Christal M.M. Mickle
Portfolio Pulse from Benzinga Newsdesk
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) has announced that Neil F. McFarlane will take over as President and CEO, succeeding interim CEO Christal M.M. Mickle, effective October 10, 2023. Mickle will continue in her role as Chief Development Officer. The company also confirmed the retirement of Joseph B. Saluri from the Board of Directors.
October 10, 2023 | 11:34 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zevra Therapeutics has announced a change in leadership with Neil F. McFarlane taking over as CEO. This could potentially bring new strategic directions for the company.
Leadership changes can have significant impacts on a company's strategic direction and operations. However, it's too early to predict the exact impact of this change on Zevra Therapeutics' stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100